ACE2 and COVID-19: In addition, ACE2 is a functional receptor for SARS-CoV-2, the coronavirus that caused the COVID-19 pandemic in 2020, and recombinant ACE2 has entered clinical trials (NCT04335136) for COVID-19 (Bao et al., 2020).